Lamisil (Terbinafine Hydrochloride)

Terbinafine blocks the fungal enzyme squalene epoxidase, which is essential for producing ergosterol, a key component of fungal cell membranes. Inhibition leads to toxic buildup of squalene and loss of ergosterol, disrupting membrane integrity and causing fungal cell death while sparing human cells.

The prescribed dose of Lamisil is determined by a qualified healthcare professional based on the specific infection, severity, and patient characteristics. Typically, the cream is applied once or twice daily to the affected area for a defined treatment period, but exact instructions should follow the prescriber’s order.

Safety data for topical terbinafine in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using Lamisil. The prescriber will decide if treatment is appropriate.

To order Lamisil, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide. After the request, the sales team will verify trade or institutional credentials and respond with pricing, availability, shipping details and any required import documentation.

Lamisil (terbinafine) belongs to the allylamine class, which inhibits squalene epoxidase, whereas azole antifungals block lanosterol 14‑α‑demethylase. Allylamines often achieve faster fungicidal activity and are effective against dermatophytes, while azoles have a broader spectrum but may be more prone to resistance. Choice depends on infection type and clinician judgment.

Lamisil should be stored at room temperature, typically below 25 °C (77 °F). Keep the product in its original container, protect it from moisture, direct sunlight and excessive heat. Do not freeze the cream, and ensure the cap is tightly closed to maintain stability.

The cream is applied to clean, dry skin of the affected area. A thin layer is spread gently and rubbed in until fully absorbed. The usual frequency is once or twice daily, as directed by the prescriber, and treatment should continue for the full course even if symptoms improve early.

Although rare, serious adverse reactions can include severe allergic responses such as angioedema or anaphylaxis, extensive skin reactions like Stevens‑Johnson syndrome, and, in exceptional cases of systemic absorption, liver enzyme elevations. Patients should seek immediate medical attention if they notice swelling, blistering, or signs of liver dysfunction.

Lamisil should be avoided in individuals with a known hypersensitivity to terbinafine or any cream excipients. It is also not recommended for use on extensive broken skin, on more than 20 % of body surface without medical supervision, or in patients with severe hepatic impairment unless specifically advised by a physician.